🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating how ruxolitinib affects premalignant breast cells....
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-05-13
Trial ID
NCT02928978
Treatments Being Tested
A protocol named as "HLH-DR" for patients with refractory and secondary hem...
Status
Unknown
Location
Yan Yue
Start Date
2017-03-01
Trial ID
NCT03795909
Treatments Being Tested
Phase 1, single -center study in 2 parts. The study designs for each part a...
Status
Completed
Location
Nucleus Network Brisbane
Start Date
2020-09-10
Trial ID
NCT04456634
The purpose of this study was to determine whether ruxolitinib added to cap...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01423604
Treatments Being Tested
The COVID-19 pandemic has had a dramatic effect in public health worldwide....
Status
Terminated
Location
Hospital das Clínicas
Start Date
2020-08-14
Trial ID
NCT04477993
Treatments Being Tested
The purpose of this study was to determine if ruxolitinib, in combination w...
Status
Terminated
Location
Multiple Locations
Start Date
2014-02-11
Trial ID
NCT02119650
Treatments Being Tested
Medical approaches remain the gold standard treatment for non-segmental for...
Status
Completed
Location
CHU de Nice - Hôpital de l'Archet
Start Date
2023-09-05
Trial ID
NCT05872477
Treatments Being Tested
The purpose of this trial is to evaluate whether treatment with pelabresib ...
Status
Recruiting
Location
Yale University School Of Medicine
Start Date
2026-06-16
Trial ID
NCT07357727
Treatments Being Tested
This multicenter, randomized, double-blind, placebo-controlled study will e...
Status
Completed
Location
Florida Cancer Specialists-Broadway, Fort Myers
Start Date
2016-01-25
Trial ID
NCT02593760
Treatments Being Tested
The purpose of the study is to assess the efficacy and safety of ruxolitini...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2021-07-19
Trial ID
NCT04921969
Treatments Being Tested